Thompson Peter A

Director at Trubion Pharmaceuticals, Inc · on record since Oct 19, 2006
President and CEO at Trubion Pharmaceuticals, Inc · on record since May 26, 2009
Director at Anthera Pharmaceuticals Inc · on record since Feb 10, 2011
Director at Sionna Therapeutics, Inc. · on record since Apr 16, 2026
Director at RESPONSE BIOMEDICAL CORP · on record since Jan 9, 2012
Interim Chief Exec Officer at RESPONSE BIOMEDICAL CORP · on record since Jan 9, 2012
Director at NIKU CORP · on record since Jul 16, 2004
Director at Mirati Therapeutics, Inc. · on record since Jul 12, 2013
Director at Janux Therapeutics, Inc. · on record since Jun 16, 2021
Director at Corvus Pharmaceuticals, Inc. · on record since Jun 15, 2026
10% owner at Corvus Pharmaceuticals, Inc. · on record since Jun 15, 2026
10% owner at Janux Therapeutics, Inc. · on record since Jun 14, 2021
Director at Sierra Oncology, Inc. · on record since Jul 21, 2015
Director at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
10% owner at RESPONSE BIOMEDICAL CORP · on record since Jun 20, 2016
Director at ALPINE AIR EXPRESS INC/DE · on record since Jul 26, 2017
10% owner at ALPINE AIR EXPRESS INC/DE · on record since Jul 26, 2017
Director at Principia Biopharma Inc. · on record since Sep 13, 2018
Director at · on record since Dec 13, 2018
10% owner at · on record since Dec 13, 2018
Director at · on record since Jun 26, 2019
10% owner at · on record since Jun 26, 2019
Director at · on record since Sep 29, 2020
10% owner at · on record since Sep 29, 2020
Director at · on record since Dec 8, 2020
Director at · on record since Mar 31, 2021
10% owner at · on record since Mar 31, 2021
Director at · on record since Feb 19, 2021
10% owner at · on record since Feb 19, 2021
10% owner at · on record since Dec 8, 2020

Insider trading activity of Thompson Peter A

Transactions on record: 336; since Jul 16, 2004

Open-market buys: 64; $214M

Open-market sells: 55; $143M

Companies traded: 16; last filing Jul 9, 2026

Figures computed from official regulatory filings — .

Companies where Thompson Peter A has traded

26 tx · $65.6M · Jul 9, 2026
21 tx · $40.7M · Jun 26, 2026
19 tx · $26.7M · Jun 17, 2026
71 tx · $42.4M · Jun 15, 2026
30 tx · $50.6M · May 20, 2024
10 tx · $30M · Jun 21, 2022
16 tx · $22.6M · Jun 16, 2022
8 tx · $15M · Jan 26, 2021
12 tx · $17.1M · Sep 29, 2020
8 tx · $379.1M · Jan 24, 2020
13 tx · $37.6M · Jun 6, 2018
34 tx · $500K · Dec 1, 2016
4 tx · $3.4M · Jul 21, 2015
3 tx · May 10, 2012

Track record of Thompson Peter A

Statistical track record

Free account

Open-market buys: 67

Last buy: Apr 3, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Thompson Peter A

Co-insiders of Thompson Peter A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sionna Therapeutics, Inc.Listing unverified	Jul 9, 2026	Sell	-85,918	44.86 USD	$3.9M		SEC
Sionna Therapeutics, Inc.Listing unverified	Jul 2, 2026	Sell	-115,844	45.50 USD	$5.3M		SEC
ARS Pharmaceuticals, Inc.Listing on record	Jun 26, 2026	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sionna Therapeutics, Inc.Listing unverified	Jun 18, 2026	AwardD (derivative)	17,340	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Edgewise Therapeutics, Inc.Listing on record	Jun 17, 2026	AwardD (derivative)	16,377	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jun 15, 2026	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sionna Therapeutics, Inc.Listing unverified	May 29, 2026	Sell	-101	44.49 USD	$4.5K		SEC
Sionna Therapeutics, Inc.Listing unverified	May 11, 2026	Sell	-184,639	46.22 USD	$8.5M		SEC
Sionna Therapeutics, Inc.Listing unverified	May 11, 2026	Sell	-48,546	44.61 USD	$2.2M		SEC
Sionna Therapeutics, Inc.Listing unverified	May 11, 2026	Sell	-59,767	44.58 USD	$2.7M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 21, 2026	Sell	-2,948	44.52 USD	$131.2K		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 21, 2026	Sell	-52,397	44.68 USD	$2.3M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 16, 2026	Sell	-47,814	44.51 USD	$2.1M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 16, 2026	Sell	-235,863	44.64 USD	$10.5M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 16, 2026	Sell	-226,906	45.34 USD	$10.3M		SEC
Sionna Therapeutics, Inc.Listing unverified	Feb 4, 2026	Sell	-29,063	44.58 USD	$1.3M		SEC
Sionna Therapeutics, Inc.Listing unverified	Feb 4, 2026	Sell	-1,890	44.57 USD	$84.2K		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	Exercise	15,000	2.12 USD	$31.8K		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	Exercise	15,000	1.64 USD	$24.6K		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	Exercise	15,000	3.27 USD	$49.1K	Unusual size	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Sionna Therapeutics, Inc.Listing unverified	Jul 9, 2026	Sell	-85,918	44.86 USD	$3.9M		SEC
Sionna Therapeutics, Inc.Listing unverified	Jul 2, 2026	Sell	-115,844	45.50 USD	$5.3M		SEC
ARS Pharmaceuticals, Inc.Listing on record	Jun 26, 2026	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sionna Therapeutics, Inc.Listing unverified	Jun 18, 2026	AwardD (derivative)	17,340	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Edgewise Therapeutics, Inc.Listing on record	Jun 17, 2026	AwardD (derivative)	16,377	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jun 15, 2026	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Sionna Therapeutics, Inc.Listing unverified	May 29, 2026	Sell	-101	44.49 USD	$4.5K		SEC
Sionna Therapeutics, Inc.Listing unverified	May 11, 2026	Sell	-184,639	46.22 USD	$8.5M		SEC
Sionna Therapeutics, Inc.Listing unverified	May 11, 2026	Sell	-48,546	44.61 USD	$2.2M		SEC
Sionna Therapeutics, Inc.Listing unverified	May 11, 2026	Sell	-59,767	44.58 USD	$2.7M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 21, 2026	Sell	-2,948	44.52 USD	$131.2K		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 21, 2026	Sell	-52,397	44.68 USD	$2.3M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 16, 2026	Sell	-47,814	44.51 USD	$2.1M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 16, 2026	Sell	-235,863	44.64 USD	$10.5M		SEC
Sionna Therapeutics, Inc.Listing unverified	Apr 16, 2026	Sell	-226,906	45.34 USD	$10.3M		SEC
Sionna Therapeutics, Inc.Listing unverified	Feb 4, 2026	Sell	-29,063	44.58 USD	$1.3M		SEC
Sionna Therapeutics, Inc.Listing unverified	Feb 4, 2026	Sell	-1,890	44.57 USD	$84.2K		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	Exercise	15,000	2.12 USD	$31.8K		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	Exercise	15,000	1.64 USD	$24.6K		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	ExerciseD (derivative)	-15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Jan 30, 2026	Exercise	15,000	3.27 USD	$49.1K	Unusual size	SEC